Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation.

Saved in:
Bibliographic Details
Title: Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation.
Authors: Almarghalani NA; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.; Immunology Research Program, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.; Health and Life Research Center, Taibah University, Madinah, Saudi Arabia., Ganash MA; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia., Alharbi MG; Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia., Abualfaraj T; Health and Life Research Center, Taibah University, Madinah, Saudi Arabia.; Department of Basic Medical Sciences, College of Medicine, Taibah University, Madinah, Saudi Arabia., Alkayyal AA; Immunology Research Program, King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.; Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia., Mahmoud AB; Health and Life Research Center, Taibah University, Madinah, Saudi Arabia.; Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
Source: Frontiers in oncology [Front Oncol] 2026 Jul 13; Vol. 16, pp. 1824087. Date of Electronic Publication: 2026 Jul 13 (Print Publication: 2026).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first